Astareal NMN + Astaxanthin Supplement for Medical Institutions to be Released on April 15, 2026
Astareal Co., Ltd. will launch "Astareal NMN + Astaxanthin," a supplement containing NMN and astaxanthin, exclusively for medical institutions on April 15, 2026. The product focuses on cellular function support and anti-aging. It is manufactured in a domestic GMP-certified factory and contains 250mg NMN, 12mg astaxanthin, and 100mg water chestnut extract per 4 capsules. The suggested retail price is 15,984 JPY (tax included).
📋 Article Processing Timeline
- 📰 Published: April 13, 2026 at 20:00
- 🔍 Collected: April 13, 2026 at 16:35
- 🤖 AI Analyzed: April 13, 2026 at 19:03 (2h 28m after Collected)
Astareal Co., Ltd., headquartered in Kamiichi-machi, Nakaniikawa-gun, Toyama Prefecture, with Mitsugu Fujii as Representative Director, announced the new release of "Astareal NMN + Astaxanthin" on April 15, 2026. This supplement, exclusively for medical institutions, combines NMN (250mg per 4 capsules), known for supporting energy production and its relation to sirtuin genes, and Astaxanthin (12mg per 4 capsules), a powerful antioxidant. It also includes Hishiekisu (water chestnut extract) (100mg per 4 capsules) for beauty and health maintenance. The product is manufactured in a domestic GMP-certified factory with strict quality control and external verification of ingredient stability. It is packaged in individual packets (4 capsules per packet, 30 packets per box) for hygiene and convenience. The suggested retail price is 15,984 JPY (14,800 JPY + tax). Astareal Co., Ltd. is a pioneer in astaxanthin research and development, aiming to contribute to public health by providing academically evidenced and nutritionally balanced products for healthcare professionals.